NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioCurate

BioCurate

Melbournebiocurate.com

Overview

BioCurate is an Australian venture catalyst and investment firm that bridges the gap between academic biomedical research and industry by providing expertise, project management, and financial resources to translate early-stage discoveries into therapeutic candidates.

Year Founded

2016

Portfolio Companies

1

Investments

BioCurate investments
CompanyDateStageLead
xCystence BioMar 2026Pre SeedCo-investor

Key People

Kathy Nielsen

Chief Executive Officer

Ken Jefferd

Non Executive Director

Frederico Calhabeu

Director of Cell and Gene Therapies

Jaclyn Sceneay

Director Translational Biology

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMelbourne
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.